The selected candidate will conduct translational PhD research under the supervision of Prof. Greet Van den Berghe and Prof. Lies Langouche. You will join the Intensive Care Medicine Research Group, part of the department of Cellular and Molecular Medicine at the University of Leuven (KU Leuven, Belgium). We are a multidisciplinary, translational basic/clinical research team that combines a research laboratory with a large intensive care unit (ICU). This unique combination allows effective cross-talk between knowledge generated from patient studies and from animal and molecular studies in the laboratory.
Website unit
Our research focuses on critical illness, caused by sepsis, complicated surgery or extensive trauma, causing impaired organ function to the extent that the patient would die shortly when not receiving intensive medical care. Although modern intensive care has reduced mortality, a large number of survivors continue to require such supportive care in the ICU for weeks or months. Lingering unresolving organ failure then becomes the main driver of poor short- and long-term outcome irrespective of the initial diagnosis upon admission. Research from our group has focused on two of these unresolved problems, namely ICU-acquired muscle weakness and ICU-acquired adrenal insufficiency, for which there is either no treatment or treatment.
This project will address the hypothesis that ICU-acquired adrenal insufficiency and ICU-acquired muscle weakness share upstream underlying mechanisms, pathways that are currently unexplored and that can be manipulated with the potential to reverse both problems together. We will test this hypothesis via an experimental and a clinical track. We will make use of our clinically relevant mouse model of intensive-care-supported critical illness to selectively target specific molecular pathways. For translational purposes, we will also use human plasma and tissue biopsies and extensive clinical data prospectively collected.
Keywords: Critical illness, sepsis, endocrinology, inflammation, metabolism
For more information please contact Prof. dr. Lies Langouche, tel.: +32 16 33 05 24, mail: lies.langouche@kuleuven.be or Prof. dr. Greet Van den Berghe, tel.: +3216344021, mail: greet.vandenberghe@kuleuven.be.
KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.
KU Leuven is an autonomous university. It was founded in 1425. It was born of and has grown within the Catholic tradition.
Visit the employer page